brph institucional agosto v11 eng v3
DESCRIPTION
TRANSCRIPT
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
e
20
13
e
20
14
e
20
15
e
20
16
e
20
17
e
20
18
e
20
19
e
20
20
e
-20% -10% 0% 10% 20%
0 - 9
10 - 19
20 - 29
30 - 39
40 - 49
50 - 59
60 - 69
70 - 79
80+
Europe 2010 Brazil 2030
-20% -10% 0% 10% 20%
0 - 910 - 1920 - 2930 - 3940 - 4950 - 5960 - 6970 - 79
80+
Europe 2010 Brazil 2010
1 1
72881109
96
90333
1
Shares under lock-up
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
MAPPING
PLUG-IN
CONTINUOUS IMPROVEMENT
1
2
3
Admission to Termination
Calculation and Collection
Calculating Results
Administrative-Financial
Administrative Support
IT Support
PA
S
Ce
nte
r S
ha
red
Serv
ices -
SS
C
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
••
•
•
Dermocosmetics space to displays
premium products
Gondola point: Clusterizing stores by customer
profile to maximize potential of products
exposure
Check-out display: High turnover products to
encourage impulse purchase
Category management: Intelligence organization
depending on consumption drive
EVOLUTION OF FARMAIS STORE BASE
FARMAIS EXPANSION
•
•
•
FINANCIAL RESULTS OPERATIONAL RESULTS
132
210
118
248
249
96 29
15 2
2011 Aquisição Cresc. orgânico Fechamento Cresc. orgânico Fechamento 2012
132
210
118
248
249
96 29
15 2
2011 Aquisição Cresc. orgânico Fechamento Cresc. orgânico Fechamento 2012
1
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
378
708
Working capial 2Q12 4Q12 1Q13 2Q13
Accounts receivable 25 23 24 18
Inventories 92 95 106 109
Suppliers 54 58 55 73
Working capital in days 63 60 75 53
Cash position and indebtedness (R$'000) 2Q12 4Q12 1Q13 2Q13
(+) Loans and financing 159,908 177,049 169,079 160,228
Short term 48,123 83,229 44,864 41,694
Long term 111,785 93,820 124,215 118,534
(+) Debentures 254,879 253,642 258,937 253,964
Short term 6,688 5,237 10,427 5,348
Long term 248,191 248,405 248,510 248,616
(+) Accounts payable for investment acquisition 498,242 345,333 264,430 232,581
Short term 244,986 99,711 82,833 81,986
Long term 253,256 245,622 181,597 150,595
(=) Total Indebtedness 913,029 776,024 692,446 646,773
Short term (%) 32.8% 24.2% 19.9% 19.9%
Long term (%) 67.2% 75.8% 80.1% 80.1%
(-) Cash and cash equivalents (411,267) (368,751) (183,870) (162,205)
(=) Net Debt 501,762 407,273 508,576 484,568
Net debt/Adjusted EBITDA (LTM) 2.9 X 2.1 X 2.7 X 2.5 X
4.7 3.0
2.2 1.1
2.3 1.9 1.0 2.1 3.0 1.5 3.1
4.1 5.2
6.9
6.8
13.4
11.3
7.5
6.3
15.3 11.4
12.6
10.1
12.0 8.0
7.0 7.4
6.9 7.8 8.1
8.6 8.4 9.3
10.5 10.1 9.8
11.2
12.1 12.3 12.3
13.1 13.6
14.4 15.1
14.6
13.1 12.7
11.0
Jul-1
1
Aug-1
1
Sep-1
1
Oct-
11
No
v-1
1
De
c-1
1
Jan-1
2
Feb
-12
Ma
r-1
2
Apr-
12
Ma
y-1
2
Jun-1
2
Jul-1
2
Aug-1
2
Sep-1
2
Oct-
12
No
v-1
2
De
c-1
2
Jan-1
3
Feb
-13
Ma
r-1
3
Apr-
13
Ma
y-1
3
Jun-1
3
Vol. R$ Médio diário (Milhão)
P. Médio (R$/ação)
Ju
n-1
1
Ju
l-1
1
Aug
-11
Sep
-11
Oct-
11
Nov-1
1
Dec-1
1
Ja
n-1
2
Feb-1
2
Ma
r-12
Apr-
12
Ma
y-1
2
Ju
n-1
2
Ju
l-1
2
Aug
-12
Sep
-12
Oct-
12
Nov-1
2
Dec-1
2
Ja
n-1
3
Feb-1
3
Ma
r-13
Apr-
13
Ma
y-1
3
Ju
n-1
3
Brasil Pharma
IBOV
BPHA3 06.30.13 Market closure
Shares outstanding 256.384.419
Price (R$/share) 10.26
Annual Performance -28.8%
Ibovespa Index -22.1%
Perfomance since IPO¹ 19.0%
Ibovespa Index -22.2%
Market Cap (R$ Bn) 2.6
Average daily trading volume in 2013 (R$ million) 12.4
2013 2014 2015
Brasil Pharma 13,5x 9,7x 7,7x
2013 2014 2015
Brasil Pharma 0,8x 0,7x 0,6x
2013 2014 2015
Brasil Pharma 32,4x 17,3x 12,3x
EV/EBITDA
EV/Sales
P/E
•
•
•
•
•
•
•
•
•
•
•
5.8 6.2 6.0 6.3 6.5 5.8 5.8 8.5 9.3
13.9
19.2
11.8 15.2
11.8
6.7 8.3 10.6 9.0 9.5 11.4 7.1
7.0
9.9 11.0 10.4 12.0
34.0
11.7 12.4 12.3
26.7 30.7
45.6
25.7
33.3
19.0 14.3
17.5 21.9
19.1 18.0 19.2
11.8 12.3
0
10000
20000
30000
40000
50000
60000
0
1000
2000
3000
4000
5000
6000
7000
6.2
8.9 7.8
10.4 10.3 9.2
7.9 9.2
10.8
15.1
18.5 18.9
22.8 21.3
18.1
14.6 14.0 15.6 14.8
11.8
8.8 7.5
21
11.4
16.2 14.2
19.2 18.9 16.6
14.1 16.2
18.6
24.6
30.4 29.8
37.5
34.8
29.9
24 22.9
26.3
23.8
21.1 18.8
0
10000
20000
30000
40000
50000
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5,8 6,2 6,0 6,3 6,5 5,8 5,88,5 9,3
13,9
19,2
11,8
15,2
11,8
6,78,3
10,69,0 9,5
11,4
7,1
7,0
9,9 11,0 10,412,0
34,0
11,7 12,4 12,3
26,7
30,7
45,6
25,7
33,3
19,0
14,3
17,5
21,919,1
18,019,2
11,8 12,3
0,0
10000,0
20000,0
30000,0
40000,0
50000,0
60000,0
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
market cap EV/EBITDA P/E
0,0
1000,0
2000,0
3000,0
4000,0
5000,0
6000,0
7000,0
CVS CAREMARK
EBITDA
